The Clinical Translation Education Group (CTEG) hosted a full-day workshop titled the Introduction to Intellectual Property (IP) & Entrepreneurship for Biotherapeutic Scientists. The workshop was held on September 14, 2018 at the Chestnut Residence & Conference Centre in Toronto, Canada. The focus was on understanding the integral concepts of IP, including how to conduct a patent search, and issues related to starting your own company, such as financing the development of a discovery, making a business plan, and tips, tricks and lessons learned from experts in the biotechnology sector. The workshop was sponsored by the Centre for Commercialisation of Cancer Immunotherapy, Turnstone Biologics, the University of Toronto and Medicine by Design.
In 2017, CTEG organized a one-day workshop with the aim of providing an overview of the entire clinical translation pathway. This workshop, called Bench to Bedside for Biotherapeutics (B3), was held on Thursday, October 5, 2017 at the MaRS Discovery District in Toronto, Canada. Presenters introduced concepts related to the sequential stages characterizing the development of a cell therapy or other biotherapy to treat diseases.
The CTEG is a collaboration, formed in 2016, between seven organizations involved in experimental clinical cellular therapy to address the absence of a high-quality, structured educational training program in clinical translation of biotherapeutics. Its vision is to develop a training strategy in clinical translation to cover aspects of research translation from early discovery to the clinical trial and commercialization stage. Participating organizations include BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and the Stem Cell Network.
MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
CCRM is grateful to the Government of Canada and the Province of Ontario for their ongoing support.